Literature DB >> 23291537

HIV infection deregulates innate immunity to malaria despite combination antiretroviral therapy.

Constance A M Finney1, Kodjo Ayi, James D Wasmuth, Prameet M Sheth, Rupert Kaul, Mona R Loutfy, Kevin C Kain, Lena Serghides.   

Abstract

OBJECTIVE: Malaria and HIV-1 adversely interact, with HIV-positive individuals suffering higher parasite burdens and worse clinical outcomes. However, the mechanisms underlying these disease interactions are unclear. We hypothesized that HIV coinfection impairs the innate immune response to malaria, and that combination antiretroviral therapy (cART) may restore this response. Our aim was to examine the innate inflammatory response of natural killer (NK), natural killer T (NKT), and γδ T-cells isolated from the peripheral blood of HIV-infected therapy-naive donors to malaria parasites, and determine the effect of cART on these responses.
METHODS: Freshly isolated peripheral blood mononuclear cells from 25 HIV-infected individuals pre-cART (month 0) and post-cART (months 3 and 6), and HIV-negative individuals at matched time-points, were cultured in the presence of Plasmodium falciparum parasitized erythrocytes. Supernatants and cells were collected to assess cytokine production and phenotypic changes.
RESULTS: Compared to HIV-negative participants, NKT, NK, and γδ T-cell subsets from participants with chronic HIV infection showed marked differences, including decreased production of interferon γ (IFNγ) and tumor necrosis factor (TNF) in response to malaria parasites. IFNγ production was linked to interleukin-18 receptor (IL-18R) expression in all three cell types studied. Six months of cART provided partial cellular reconstitution but had no effect on IL-18R expression, or IFNγ and TNF production.
CONCLUSION: These data suggest that HIV infection impairs the inflammatory response of innate effector cells to malaria, and that the response is not fully restored within 6 months of cART. This may contribute to higher parasite burdens and ineffective immune responses, and have implications for vaccination initiatives in coinfected individuals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291537     DOI: 10.1097/QAD.0b013e32835b3dfa

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection.

Authors:  Constance Finney; Lena Serghides
Journal:  J Vis Exp       Date:  2015-10-06       Impact factor: 1.355

2.  HIV vaccine trial exploits a dual and central role for innate immunity.

Authors:  Deborah Heydenburg Fuller; Laura E Richert-Spuhler; Nichole R Klatt
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

3.  Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework.

Authors:  Mark J Siedner
Journal:  J Aging Health       Date:  2017-08-23

Review 4.  Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors:  Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 5.  HIV and co-infections.

Authors:  Christina C Chang; Megan Crane; Jingling Zhou; Michael Mina; Jeffrey J Post; Barbara A Cameron; Andrew R Lloyd; Anthony Jaworowski; Martyn A French; Sharon R Lewin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

6.  Severity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study.

Authors:  Abigail Norris Turner; Sammy Tabbah; Victor Mwapasa; Stephen J Rogerson; Steven R Meshnick; William E Ackerman; Jesse J Kwiek
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-01       Impact factor: 3.731

7.  The impact of HIV on presentation and outcome of bacterial sepsis and other causes of acute febrile illness in Gabon.

Authors:  Michaëla A M Huson; Rachel Kalkman; Sebastiaan M Stolp; Saskia Janssen; Abraham S Alabi; Justin O Beyeme; Tom van der Poll; Martin P Grobusch
Journal:  Infection       Date:  2015-03-11       Impact factor: 3.553

Review 8.  Tim-3: an activation marker and activation limiter of innate immune cells.

Authors:  Gencheng Han; Guojiang Chen; Beifen Shen; Yan Li
Journal:  Front Immunol       Date:  2013-12-10       Impact factor: 7.561

9.  Malawian children with uncomplicated and cerebral malaria have decreased activated Vγ9Vδ2 γδ T cells which increase in convalescence.

Authors:  Visopo Harawa; Madi Njie; Thomas Keller; Kami Kim; Anthony Jaworowski; Karl Seydel; Stephen J Rogerson; Wilson Mandala
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

Review 10.  HIV coinfection influences the inflammatory response but not the outcome of cerebral malaria in Malawian children.

Authors:  Emmie W Mbale; Christopher A Moxon; Mavuto Mukaka; Maganizo Chagomerana; Simon Glover; Ngawina Chisala; Sofia Omar; Malcolm Molyneux; Karl Seydel; Alister G Craig; Terrie Taylor; Robert S Heyderman; Macpherson Mallewa
Journal:  J Infect       Date:  2016-06-14       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.